NR4A1 promotes the expression of inhibitory receptors, such as programmed cell death-1 (PD-1), leading to the depletion or dysfunction of CAR T cells, which ultimately allows lung cancer cells to evade the immune response (70, 71). This evidence concerns the gene PDCD1 and lung carcinoma.